Inventiva (IVA) Operating Income (2019 - 2021)
Inventiva (IVA) posted quarterly Operating Income of -$16.5 million for Q2 2021, down 68.62% year-over-year from -$52.4 million in Q2 2020, and down 37.21% quarter-over-quarter from -$12.0 million in Q1 2021.
Analysis
Inventiva (IVA) Operating Income (2019 - 2021) Analysis & Trends
Inventiva's Operating Income history runs 3 years deep, the most recent figure standing at -$16.5 million for Q2 2021.
- In Q2 2021, Operating Income fell 68.62% year-over-year to -$16.5 million; the TTM figure through Jun 2021 stood at -$73.6 million (changed N/A YoY), while the FY2025 annual figure was -$164.1 million, down 57.45% from the prior year.
- Operating Income for Q2 2021 stood at -$16.5 million, down from -$12.0 million in the prior quarter.
- The five-year high for Operating Income was -$7.5 million in Q1 2020, with the low at -$35.4 million in Q4 2020.
- The 3-year median for Operating Income is -$14.2 million (2021), against an average of -$19.1 million.
- The sharpest annual moves came in 2020 and 2021: Operating Income retreated 5.6% in 2020, then sank 68.62% in 2021.
- Inventiva's Operating Income stood at -$33.6 million in 2019, then slipped by 5.6% to -$35.4 million in 2020, then jumped by 53.56% to -$16.5 million in 2021.
- Business Quant data shows IVA's Operating Income at -$16.5 million in Q2 2021, -$12.0 million in Q1 2021, and -$35.4 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |